Which laboratory tests should be ordered to evaluate for hereditary hemochromatosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Testing for Hemochromatosis

Order fasting transferrin saturation (TS) and serum ferritin simultaneously as the initial screening tests for hemochromatosis. 1, 2

Initial Screening Tests

The diagnostic workup begins with two essential iron studies that should be obtained together rather than relying on a single test:

  • Transferrin saturation (TS): Should be drawn in the morning (fasting does not improve diagnostic utility per the most recent guidelines) 1
  • Serum ferritin: Obtained simultaneously with TS 2

Interpretation Thresholds for Iron Overload

Females:

  • TS >45% AND ferritin >200 µg/L suggests iron overload 1

Males:

  • TS >50% AND ferritin >300 µg/L suggests iron overload 1

If either test is abnormal (TS ≥45% or ferritin above the upper limit of normal), proceed to genetic testing 2.

Confirmatory Genetic Testing

HFE genotyping for p.C282Y mutation should be performed in individuals of European origin with biochemical evidence of iron overload (as defined above) with or without clinical symptoms 1. This is the critical next step after abnormal iron studies.

The HFE test should specifically evaluate:

  • p.C282Y homozygosity (most common, >80% of cases)
  • p.C282Y/H63D compound heterozygosity
  • p.C282Y heterozygosity 2

Additional Laboratory Tests for Risk Stratification

Once hemochromatosis is confirmed, obtain these tests to assess for cirrhosis risk:

  • Liver enzymes (ALT/AST): Elevated levels combined with ferritin >1000 µg/L predict cirrhosis risk 2
  • Platelet count: Count <200 combined with ferritin >1000 µg/L and elevated aminotransferases predicts cirrhosis in 80% of C282Y homozygotes 2

Key prognostic marker: Ferritin <1000 µg/L is an accurate predictor for the absence of cirrhosis 2.

Important Caveats

Ferritin Limitations

Ferritin is not specific for iron overload—it is also an acute phase reactant elevated in:

  • Fatty liver disease and metabolic syndrome
  • Alcohol-related liver disease
  • Inflammation and infection
  • Malignancy
  • Hepatocellular necrosis 1

Critical point: An elevated ferritin with normal TS may be nonspecific and not indicate hemochromatosis. Conversely, iron overload can exist with elevated ferritin but normal TS, particularly in non-HFE hemochromatosis or C282Y/H63D compound heterozygotes 2.

Transferrin Saturation Limitations

Elevated TS can occur in conditions with decreased transferrin levels:

  • Alcohol-related liver disease or cirrhosis
  • Dyserythropoiesis
  • Chronic hemolysis
  • Transfusion-dependent states 1

Family Screening Protocol

For first-degree relatives of confirmed hemochromatosis patients, order both tests simultaneously at a single visit:

  • HFE genotyping
  • Transferrin saturation and ferritin 2

This dual approach allows for immediate risk assessment without requiring multiple visits.

When to Consider Advanced Testing

If HFE testing is negative but iron overload persists without alternative explanation, consider:

  • Liver MRI for iron quantification
  • Liver biopsy with hepatic iron concentration measurement
  • Genetic testing for non-HFE hemochromatosis genes (should be performed at specialized referral centers) 2, 3, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.